Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Appl Microbiol ; 131(1): 135-145, 2021 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-33251637

RESUMO

AIMS: The study was aimed to evaluate the antibacterial activity and efficacy of chestnut and quebracho wood extracts against Salmonella by in vitro assays and in vivo trials. METHODS AND RESULTS: The extracts showed inhibitory activity against Salmonella determined by the minimum inhibitory concentration method as well as on the adhesion and invasion of S. Gallinarum (SG) and S. Enteritidis (SE) in Caco-2 cells. Also, transmission electron microscopy revealed that extract-treated Salmonella showed disruption of cell walls and membranes, damage of the cytoplasm and tannin-protein aggregations. In addition, efficacy of the extracts to control SG and SE was evaluated in experimental infection trials in laying hens and broilers respectively. SE excretion was significantly reduced on days 5 (P < 0·01) and 12 (P < 0·025) only in the quebracho group. In the fowl typhoid infection model, hens that received the chestnut extract showed a significantly reduced mortality (P < 0·05). CONCLUSIONS: Our results evidence that these alternative natural products may be a useful tool to control Salmonella in poultry. SIGNIFICANCE AND IMPACT OF THE STUDY: Salmonella is a zoonotic pathogen usually associated with poultry production. This study provides information about the mechanism of antibacterial effects of chestnut and quebracho wood extracts to control Salmonella in poultry.


Assuntos
Galinhas/microbiologia , Extratos Vegetais/farmacologia , Salmonelose Animal/prevenção & controle , Salmonella/efeitos dos fármacos , Taninos/farmacologia , Animais , Antibacterianos/química , Antibacterianos/farmacologia , Membrana Externa Bacteriana/efeitos dos fármacos , Células CACO-2 , Parede Celular/efeitos dos fármacos , Humanos , Testes de Sensibilidade Microbiana , Extratos Vegetais/química , Doenças das Aves Domésticas/microbiologia , Madeira/química
2.
Biomed Res Int ; 2016: 3278359, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27747227

RESUMO

Necrotic enteritis (NE) is an important concern in poultry industry since it causes economic losses, increased mortality, reduction of bird welfare, and contamination of chicken products for human consumption. For decades, the use of in-feed antimicrobial growth promoters (AGPs) has been the main strategy to control intestinal pathogens including Clostridium perfringens (CP), the causative agent of NE. However, the use of AGPs in animal diet has been linked to the emergence and transmission of antimicrobial resistance through food-borne microorganisms, which has led to the ban of AGPs in many countries. This scenario has challenged the poultry industry to search for safer alternative products in order to prevent NE. In this context, the utilization of natural plant extracts with antimicrobial properties appears as a promising and feasible tool to control NE in chicken. In this paper, we review the scientific studies analyzing the potential of plant extracts as alternative feed additives to reduce NE in poultry, with focus on two types of plant products that arise as promising candidates: tannins and essential oils. Some of these products showed antimicrobial activity against CP and coccidia in vitro and in vivo and are able to increase productive performance, emulating the bioactive properties of AGPs.


Assuntos
Anti-Infecciosos/uso terapêutico , Infecções por Clostridium/veterinária , Enterite/tratamento farmacológico , Necrose/tratamento farmacológico , Óleos Voláteis/química , Extratos Vegetais/química , Doenças das Aves Domésticas/tratamento farmacológico , Taninos/química , Animais , Antibacterianos/uso terapêutico , Anti-Infecciosos/química , Infecções por Clostridium/tratamento farmacológico , Clostridium perfringens/efeitos dos fármacos , Farmacorresistência Bacteriana , Tolerância a Medicamentos , Microbiologia de Alimentos , Testes de Sensibilidade Microbiana , Aves Domésticas
3.
Neurologia ; 25(1): 51-7, 2010.
Artigo em Espanhol | MEDLINE | ID: mdl-20388461

RESUMO

Psychogenic movement disorders are a daily challenge for the neurologist. A mistake in its recognition may have important consequences for the patients. As a result, the diagnosis must be considered very carefully in clinical practice. However, psychogenic movement disorders are not unusual, are mainly tremors, and a wrong diagnosis is common. Psychogenic is an unspecific term that usually masks the real mental disorder, and should be called somatoform disorders, factitious disorders, malingering, depression, anxiety and histrionic personality disorder, although the absence of a psychiatric diagnosis does not preclude a psychogenic cause. The diagnosis may often be difficult and should be made by an expert neurologist. Organic movement disorders must be excluded after a detailed neurological history, examination, and appropriate diagnostic studies. Psychogenic tremor is not only a diagnosis of exclusion, it can be diagnosed positively by its neurological signs, mainly: variability in frequency and amplitude, bilateral and sudden onset, non-progressive with frequent remissions, absence of finger, tongue or face tremor and coactivation of antagonistic muscles. Several tests can be useful in diagnosis, such as: accelerometry, EMG and response to placebo or suggestion. The treatment requires close cooperation between the medical team and patient. The problem must never be minimised and early diagnosis and treatment must be attempted.


Assuntos
Transtornos dos Movimentos/diagnóstico , Transtornos dos Movimentos/psicologia , Tremor/diagnóstico , Tremor/psicologia , Biorretroalimentação Psicológica , Eletromiografia , Humanos , Transtornos dos Movimentos/fisiopatologia , Transtornos dos Movimentos/terapia , Prognóstico , Transtornos Psicofisiológicos/diagnóstico , Transtornos Psicofisiológicos/fisiopatologia , Transtornos Psicofisiológicos/psicologia , Transtornos Psicofisiológicos/terapia , Transtornos Somatoformes/diagnóstico , Transtornos Somatoformes/fisiopatologia , Transtornos Somatoformes/terapia , Tremor/fisiopatologia , Tremor/terapia
4.
Clin Nutr ; 22(5): 463-71, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-14512034

RESUMO

BACKGROUND & AIMS: Dietary fiber has been proven to be beneficial in maintaining remission in human ulcerative colitis, an effect related with an increased luminal production of short-chain fatty acids (SCFA). The aim of the present study was to further investigate the mechanisms involved in the intestinal anti-inflammatory effects of dietary fiber in an experimental model of rat colitis. METHODS: HLA-B27 transgenic rats (8-10 weeks old) were fed a fiber-supplemented diet (5% Plantago ovata seeds) for 13 weeks before evaluation of the colonic inflammatory status, both histologically and biochemically. The luminal colonic production of SCFA was quantified. In vitro studies were also performed to test the interaction between two SCFA (butyrate and propionate) as inhibitors of cytokine production in THP-1 cells. RESULTS: Dietary fiber supplementation ameliorated the development of colonic inflammation in transgenic rats as evidenced by an improvement of intestinal cytoarchitecture. This effect was associated with a decrease in some of the pro-inflammatory mediators involved in the inflammatory process: nitric oxide, leukotriene B(4), tumor necrosis factor alpha (TNFalpha). The intestinal contents from fiber-treated colitic rats showed a significant higher production of SCFA, butyrate and propionate, than non-treated colitic animals. In vitro studies revealed a synergistic inhibitory effect of butyrate and propionate on TNFalpha production. CONCLUSIONS: Dietary fiber supplementation ameliorated colonic damage in HLA-B27 transgenic rats. This effects was associated with an increased production of SCFA, which can act synergistically in inhibiting the production of pro-inflammatory mediators.


Assuntos
Colite Ulcerativa/dietoterapia , Fibras na Dieta/uso terapêutico , Ácidos Graxos Voláteis/biossíntese , Mediadores da Inflamação , Animais , Células Cultivadas , Colite Ulcerativa/metabolismo , Colo/citologia , Colo/patologia , Modelos Animais de Doenças , Ácidos Graxos Voláteis/farmacologia , Feminino , Antígeno HLA-B27/genética , Organismos Geneticamente Modificados , Plantago , Psyllium , Distribuição Aleatória , Ratos , Ratos Endogâmicos F344 , Sementes , Resultado do Tratamento , Fator de Necrose Tumoral alfa/antagonistas & inibidores
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA